Celluma Light Therapy Announces Launch of Revolutionary Body Contouring Device
This Marks the Company's Eleventh FDA-Cleared Indication-for-Use
"The Celluma CONTOUR is the first LED Light Therapy device to be FDA-cleared on an Over-The-Counter basis for body contouring," commented BioPhotas President and CEO,
Low Level Light Therapy (LLLT) for body contouring is a proven, non-invasive technique to reduce the circumference of the hips, waist, and thighs safely and effectively. Red and Near-infrared light have been demonstrated in clinical trials to activate adipocytes (fat cells), making them temporarily more porous which results in the release of intracellular lipids, that are then eliminated through the body's natural metabolic processes.
The Celluma CONTOUR is driven by a proprietary algorithm that delivers light energy to the skin and underlying fat cells, resulting in a reduction of the amount of fat stored within adipose tissue, which in turn leads to reduced circumferential measurements of the waist, hips and thighs, and an improved overall appearance of the skin. In a recent observational study, participants used CONTOUR for 30 minutes, three times per week for four weeks and lost an average of two inches with no changes to their diet or exercise routines.
Commenting further on the product launch,
The CONTOUR System can be purchased as a three-panel set so the waist/hips and thighs can be treated during the same 30-minute treatment time. There is also an option to purchase a single panel CONTOUR for use over the hips, waist, and thighs in succession. For the ultimate whole-body treatment, the Celluma
DELUX and DELUX XL can now be purchased with the body contouring mode, in addition to the pain management and anti-aging modes that have made it an award-winning full-body treatment option.
About Biophotas, Inc.
In providing unique devices founded on NASA-developed technology and backed by clinical studies, BioPhotas, manufacturer of the Celluma SERIES of award-winning light therapy devices, is bringing to market safe, effective, and affordable devices that unlock the clinical power of low-level light therapy. BioPhotas develops and markets devices for healthcare providers and consumers that conveniently treat a variety of skin, hair, muscle, and joint conditions. For more information about Celluma, visit www.celluma.com.
Contact:
Sr. Marketing Manager
[email protected]
(714) 978-0080
View original content:https://www.prnewswire.com/news-releases/celluma-light-therapy-announces-launch-of-revolutionary-body-contouring-device-302076817.html
SOURCE BioPhotas, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Motorcycle Tires Market to Reach USD 26.94 Billion by 2035, Driven by Asia-Pacific Two-Wheeler Production and Electric Mobility Growth, Reports Radial Insights
- NASB Financial, Inc. Announces Financial Results
- ICEYE US Awarded Contract Under NRO's Radar Commercial Augmentation (RCA) Program
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share